GeoVax to Present COVID-19 Vaccine Data for Immunocompromised Patients
October 9, 2025 — GeoVax presents interim safety data for GEO-CM04S1 COVID-19 vaccine in immunocompromised patients at World Vaccine Congress Europe 2025. Learn about multi-antigen vaccine progress.